DOI QR코드

DOI QR Code

Complementary and Alternative Medicine Use by Gynecologic Oncology Patients in Turkey

  • Nazik, Evsen (Obstetric and Gynecologic Nursing, Department of Nursing, Adana Health School, Cukurova University) ;
  • Nazik, Hakan (Department of Obstetrics and Gynecolog, Adana Numune Education Hospital) ;
  • Api, Murat (Department of Obstetrics and Gynecolog, Adana Numune Education Hospital) ;
  • Kale, Ahmet (Department of Obstetrics and Gynecolog, Adana Numune Education Hospital) ;
  • Aksu, Meltem (Department of Obstetrics and Gynecolog, Adana Numune Education Hospital)
  • Published : 2012.01.31

Abstract

The use of complementary and alternative medicines (CAM) among women with gynecologic cancer is becoming increasingly popular. Therefore, it is important to gain insight into the prevalence and factors related to the use of CAM. The aim of this study was to assess the use of CAM in women with gynecologic cancer. This is a descriptive cross-sectional study. Data were obtained from 67 gynecological cancer patients at gynecologic oncology clinic of a hospital in Turkey between October 2009 to December 2010 using a questionnaire developed specifically for this study. The instrument included questions on socio-demographic information, disease specifics and complementary and alternative medicine usage. On the basis of women's responses, all participants were divided into 2 groups: CAM users and nonusers. The findings indicated that 61.2% of the women reported the use of 1 or more CAM therapies. There were no significant differences in the sociodemographic and clinical characteristics between CAM users and nonusers (P <0.05). The most frequently used CAM method was herbal therapy (90.2%) and the second was prayer (41.5%). The main sources of information about CAM were informal (friends/ family members). A considerable proportion (56.1%) of CAM users had discussed their CAM use with their physicians or nurses. Turkish women with gynecologic cancer frequently use CAM in addition to standard medical therapy. Nurses/ oncologists caring for women with gynecologic cancer should initiate a dialogue about usage of CAM, discussing the potential adverse effects of CAM and the patient's therapeutic goals.

Keywords

References

  1. Ades T, Yarbro HC (2000). Alternative and complementary therapies in cancer management. In: Yarbro HC, Frogge MH, Goodman M, editors. Cancer Nursing Principles and Practice, 5, 617-28.
  2. Akyuz A, Dede M, Cetintürk A, et al (2007). Self-Application of Complementary and Alternative Medicine by Patients with Gynecologic Cancer. Gynecol Obstet Invest, 64, 75-81. https://doi.org/10.1159/000099634
  3. Boon H, Stewart M, Kennard MA, et al (2000). Use of complementary/ alternative medicine by breast cancer survivors in Ontario. Prevalence Perceptions, J Clin Onc, 18, 2515-21, https://doi.org/10.1200/JCO.2000.18.13.2515
  4. Ceylan S, Hamzaoglu O, Komurcu S, Betan C, Yalcin A.(2002). Survey of the use of complementary and alternative medicine among Turkish cancer patients. Complement Ther Med, 10, 94-9. https://doi.org/10.1054/ctim.2002.0527
  5. Fasching PA, Thiel F, Nicolaisen Murmann K, et al (2007). Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer, 15, 1277-84. https://doi.org/10.1007/s00520-007-0231-1
  6. Gozum S, Tezel A, Koc M (2003). Complementary alternative treatments used by patients with cancer in eastern Turkey. Cancer Nurs, 26, 230-6. https://doi.org/10.1097/00002820-200306000-00010
  7. Gozum S, Unsal A (2004). Use of herbal therapies by older, community dwelling women. J Adv Nurs, 46, 171-8. https://doi.org/10.1111/j.1365-2648.2003.02970.x
  8. Gozum S, Arikan D, Buyukavci M (2007). Complementary and alternative medicine use in pediatric oncology patients in Eastern Turkey. Cancer Nursing, 30, 38-44. https://doi.org/10.1097/00002820-200701000-00007
  9. Henderson JW, Donatelle RJ (2004). Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altern Ther Health Med, 10, 52-7.
  10. Kav S, Pinar G, Gullu F, et al (2008). Use of complementary and alternative medicine in patients with gynecologic cancer: is this usage more prevalent? J Altern Complement Med, 14, 347-9. https://doi.org/10.1089/acm.2008.0019
  11. Kiefer D, Shah S, Gardiner P, Wechkin H (2001). Finding information on herbal therapy: a guide to useful sources for clinicians. Altern Ther Health Med, 7, 74-8.
  12. Ma X, Yu H (2006). Global burden of cancer. The Yale J of Biology and Medicine, 79, 85-94.
  13. Matthews AK, Sellergren SA, Huo D, List M, Fleming G (2007). Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med, 13, 555-62. https://doi.org/10.1089/acm.2007.03-9040
  14. Mazicioglu MM, Serin MS, Sahan H (2006). Attitude of patients with gynaecologic malignancies in selecting alternative and complementary therapies. MEJFM, 14, 12-5.
  15. Molassiotis A, Scott JA, Kearney N, et al (2006). Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer, 14, 260-267. https://doi.org/10.1007/s00520-005-0883-7
  16. National Center for Complementary and Alternative Medicine (NCCAM) (2011) What is CAM?. Available at: http://www. nccam.nih.gov (accessed 1 February 2011).
  17. Richardson MA, Sanders T, Palmer JL, Singletary SE (2000). Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Onc, 18, 2505-14. https://doi.org/10.1200/JCO.2000.18.13.2505
  18. Ritvo P, Irvine J, Katz J, et al (1999). The patient's motivation in seeking complementary therapies. Patient Educ Couns, 38, 161-5. https://doi.org/10.1016/S0738-3991(99)00063-4
  19. Shen J, Andersen R, Albert PS, et al (2002). Use of complementary/ alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med, 13, 2-8.
  20. Supoken A, Chaisrisawatsuk T, Chumworathayi B (2009). Proportion of gynecologic cancer patients using complementary and alternative medicine. Asian Pac J Cancer Prev, 10, 779-82.
  21. Swisher EM, Cohn DE, Goff BA, et al (2002). Use of complementary and alternative medicine among women with gynecologic cancers. Gynecol Oncol, 84, 363-7. https://doi.org/10.1006/gyno.2001.6515
  22. Turgay AS, Khorshid L, Eser I (2008). Effect of the first chemotherapy course on the quality of life of cancer patients in Turkey. Cancer Nursing, 31, 19-23. https://doi.org/10.1097/01.NCC.0000339248.37829.c2
  23. Von Gruenıgen VE, Whıte LJ, Kırven MS, et al (2001). A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients, Int J Gynecol Cancer, 11, 205-9. https://doi.org/10.1046/j.1525-1438.2001.01011.x
  24. Yildırım Y, Tinar S, Yorgun S, et al (2006). The use of complementary and alternative medicine (CAM) therapies by Turkish women with gynecological cancer. Eur J Gynaecol Oncol, 27, 81-5.
  25. Yildırım Y (2010) Patterns of the Use of complementary and alternative medicine in women with metastatic cancer . Cancer Nursing, 33, 194-200. https://doi.org/10.1097/NCC.0b013e3181c295ac

Cited by

  1. Use of Complementary and Alternative Medicine Among Breast Cancer Survivors in Taiwan vol.13, pp.9, 2012, https://doi.org/10.7314/APJCP.2012.13.9.4789
  2. Perception of Patients with Cancer towards Support Management Services and Use of Complementary Alternative Medicine - a Single Institution Hospital-Based Study in Saudi Arabia vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2547
  3. Positive Effects of Oral β-Glucan on Mucositis and Leukopenia in Colorectal Cancer Patients Receiving Adjuvant FOLFOX-4 Combination Chemotherapy vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3641
  4. Barriers to biomedical care and use of traditional medicines for treatment of cervical cancer: an exploratory qualitative study in northern Uganda vol.24, pp.4, 2014, https://doi.org/10.1111/ecc.12211
  5. Habb-e-Asgand, polyherbal Unani formulation, protects liver and antioxidative enzymes against paracetamol induced hepatotoxicity vol.52, pp.4, 2014, https://doi.org/10.3109/13880209.2013.863949
  6. Perception of naturopathy for female patients with metastatic gynecological cancer: A qualitative study vol.13, pp.06, 2015, https://doi.org/10.1017/S1478951515000553
  7. Effect of Relaxation With Guided Imagery on The Physical and Psychological Symptoms of Breast Cancer Patients Undergoing Chemotherapy vol.17, pp.11, 2015, https://doi.org/10.5812/ircmj.31277
  8. Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy vol.23, pp.12, 2015, https://doi.org/10.1007/s00520-015-2690-0
  9. Complementary and Alternative Medicine Use in Women With Gynecologic Malignancy Presenting for Care at a Comprehensive Cancer Center vol.25, pp.9, 2015, https://doi.org/10.1097/IGC.0000000000000549
  10. Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients’ Attitude towards CAM in a University-Based Oncology Center in Germany vol.11, pp.11, 2016, https://doi.org/10.1371/journal.pone.0165801
  11. Komplementär- und Alternativmedizin in der Radioonkologie vol.193, pp.5, 2017, https://doi.org/10.1007/s00066-017-1101-5
  12. Factors Affecting the Tendency of Cancer Patients for Religion and Spirituality: A Questionnaire-Based Study pp.1573-6571, 2017, https://doi.org/10.1007/s10943-017-0468-z
  13. European Union Project ‘BestCARE’: improving nursing care with best complementary therapy strategies pp.00208132, 2018, https://doi.org/10.1111/inr.12469
  14. Pattern of traditional medicine use by adult Saudi patients with neurological disorders vol.15, pp.1, 2015, https://doi.org/10.1186/s12906-015-0623-6